Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01340521 · ClinicalTrials.gov registry record · Phase 1
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
A Phase 1 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01340521 is a Phase 1 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT01340521, a Phase 1 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of the study is to quantitatively evaluate pituitary hormone response, follicle stimulating hormone (FSH) and luteinizing hormone (LH), to low doses of clomiphene citrate in normally fertile women.
Interventions
- DRUG Clomiphene Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 1991-03 |
| Est. Completion | 1994-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01340521
The ClinicalTrials.gov registry entry for NCT01340521 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clomiphene Citrate is the first listed.
NCT01340521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01340521 about?
NCT01340521 is a clinical study titled "Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women". The goal of the study is to quantitatively evaluate pituitary hormone response, follicle stimulating hormone (FSH) and luteinizing hormone (LH), to low doses of clomiphene citrate in normally fertile women.
What is the current status of trial NCT01340521?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 1991-03. Estimated completion is 1994-03.
What interventions are being tested in trial NCT01340521?
The interventions under investigation include: Clomiphene Citrate (DRUG).
Who is sponsoring clinical trial NCT01340521?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.